Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

New CIMA President and Co-Chair of the Association of International Certified Professional Accountants calls on finance professionals to build a thriving profession by embracing innovation, inclusion, and sustainability

New CIMA President and Co-Chair of the Association of International Certified Professional Accountants calls on finance professionals to build a thriving profession by embracing innovation, inclusion, and sustainability

...

menu
menu